Amgen Inc. (NASDAQ: AMGN) is a large market cap stock with a market cap of 122686.28. It is in the Biotechnology industry and sector Healthcare, with a current P/E of 17.24, a forward P/E of 13.36 and EPS of 9.45. At a stock price of 162.03 (-0.55%) it has a dividend yield of 2.46%.
EPS growth for the last five years have been 13.60%, more recently this last year it has grown by 35.20%. The next year growth is going to be about 9.41% and more long-term 8.48% after five years. EPS growth quarter over quarter is 18.50%. Sales growth for the past five years have been 7.60% and sales growth quarter over quarter is 9.80%.
For performance, Amgen Inc. the past week has seen a gain of 1.72%. For the last month performance for Amgen Inc. is 6.98%. While the last quarter is 1.42% and half year, 9.15%. Finally for the year, performance is 2.13%.
The 52-week high for Amgen Inc., is at -8.79%, and for the 52-week low it comes to a value of 26.88%. The 20-day simple moving average is 4.88% and 6.07% for the 200-day simple moving average.
Volatility for the week is at 1.31%, and for the month it is 1.72%. Amgen Inc., has a target price of 183.88.
In terms of debt, long term debt/equity is 1.12, and for total debt/equity Amgen Inc. has 1.2. The gross margin is 81.00%, while operating margin is 39.90%, the profit margin is 32.60%. The current ratio is 5 and the quick ratio is 4.7.
Insider ownership is at 0.20%, with instituitional ownership at 81.30%. Amgen Inc. has a payout ratio of 35.30%. With the total shares outstanding coming to 753. The shares float is 750.35, with the float short at 1.04%, with short ratio coming to 2.76.
In terms of returns, the return on assets see Amgen Inc., get 10.00%, with its returns on investment at 12.50%. Return on equity is 25.70%. So will the investors see the target price of 183.88, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.